Interventional approaches to deep vein thrombosis

American Journal of Hematology

Volumn 87, Issue SUPPL. 1, 2012, Pages

  Vedantham, Suresh ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; CENTOCOR; HEPARIN; RETEPLASE; TENECTEPLASE; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; BALLOON CATHETER; BLOOD CLOT LYSIS; CATHETER; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; ILIAC VEIN; INFERIOR CAVA VEIN OBSTRUCTION; INTERNATIONAL NORMALIZED RATIO; ISOLATED THROMBOLYSIS; LEG; LIMB SALVAGE; LOW DRUG DOSE; MECHANICAL THROMBECTOMY; PHLEBOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAPHENOUS VEIN; THROMBECTOMY; TREATMENT INDICATION; UNITED STATES; VENA CAVA FILTER;

CATHETERIZATION; ENDOVASCULAR PROCEDURES; HUMANS; HYPERTENSION; ILIAC VEIN; MECHANICAL THROMBOLYSIS; MULTICENTER STUDIES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; UNITED STATES; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 84859946345     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23145     Document Type: Article

References (55)

1. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
2. U.S. Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Department of Health and Human Services; September 15, 2008. Available at: Accessed on February 15, 2012.
3. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the post-thrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149: 698-707.
4. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011; 364: 351-360.
5. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
6. Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: A randomized, controlled trial. Ann Intern Med 2004; 141: 249-256.
7. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: Long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239: 118-126.
8. Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med 2005; 165: 1173-1178.
9. Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105-1112.
10. Guanella R, Ducruet T, Johri M, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: A prospective evaluation. J Thromb Haemost 2011; 9: 2397-2405.
11. Van Dongen CJJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3: 939-942.
12. Kahn SR. The post-thrombotic syndrome. Thromb Res 2011; 127 (Suppl 3): S89-S92.
13. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med 2001; 110: 515-519.
14. Enden T, Haig Y, Klow N, et al. Long-term outcomes after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet 2012; 379: 31-38.
15. Kahn SR, Shbaklo H, Shapiro S, et al. Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): A randomized controlled trial. BMC Cardiovasc Disord 2007; 7: 21.
16. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454S-545S.
17. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the American Heart Association. Circulation 2011; 123: 1788-1830.
18. Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: Results of a 3-part study. Arch Intern Med 2001; 161: 2105-2109.
19. Nicolaides AN, Hussein MK, Szendro G, et al. The relation of venous ulceration with ambulatory venous pressure measurements. J Vasc Surg 1993; 17: 414-419.
20. Markel A, Manzo RA, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: Incidence and time of occurrence. J Vasc Surg 1992; 15: 377-384.
21. Caps MT, Manzo RA, Bergelin RO, et al. Venous valvular reflux in veins not involved at the time of acute deep vein thrombosis. J Vasc Surg 1995; 22: 524-531.
22. Meissner MH, Manzo RA, Bergelin RO, et al. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-608.
23. Prandoni P, Frulla M, Sartor D, et al. Venous abnormalities and the post-thrombotic syndrome. J Thromb Haemost 2005; 3: 401-402.
24. Prandoni P, Lensing AWA, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960.
25. Hull RD, Marder VJ, Mah AF, et al. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: A systematic review. Am J Med 2005; 118: 456-464.
26. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-397.
27. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: A clinical review. Can J Surg 1993; 36: 359-364.
28. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982; 211: 65-68.
29. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis in an interim report of a prospective trial. Br J Surg 1979; 66: 838-843.
30. Plate G, Eklof B, Norgren L, et al. Venous thrombectomy for iliofemoral venous thrombosis-10-year results of a prospective randomized study. Eur J Vasc Endovasc Surg 1997; 14: 333-343.
31. McNamara TO, Fischer JR. Thrombolysis of peripheral arterial and graft occlusions: Improved results using high-dose urokinase. Am J Roentgenol 1985; 144: 769-775.
32. Meyerovitz MF, Polak FJ, Goldhaber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: Predictive value of venographic appearance. Radiology 1992; 184: 345-348.
33. Vedantham S, Grassi CJ, Ferral H, et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006; 17: 417-434.
34. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: Aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494.
35. Mewissen WM, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a National Multicenter Registry. Radiology 1999; 211: 39-49.
36. Parikh SR, Raabe RA, Motarjeme A, et al. Ultrasound-accelerated thrombolysis (UAT) for deep venous thrombosis (DVT): EKOS multicenter experience. J Vasc Interv Radiol Suppl 2006; 17 (2 Part 2): S49.
37. Sugimoto K, Hoffman LV, Razavi MK, et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 2003; 37: 512-517.
38. Castaneda F, Li R, Young K, et al. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: Immediate results and complications from a pilot study. J Vasc Interv Radiol 2002; 13: 577-580.
39. Razavi MK, Wong H, Kee ST, et al. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy. J Endovasc Ther 2002; 9: 593-598.
40. Vedantham S, Thorpe PE, Cardella JF, et al. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2006; 17: 435-448.
41. Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32: 130-137.
42. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: Conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001; 233: 752-760.
43. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002; 24: 209-214.
44. Vedantham S, Vesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15: 565-574.
45. Kim HS, Patra A, Paxton BE, et al. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: Clinical and economic outcomes. J Vasc Interv Radiol 2006; 17: 1099-1104.
46. Bush RL, Lin PH, Bates JT, et al. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: Safety and feasibility study. J Vasc Surg 2004; 40: 965-970.
47. Lin PH, Zhou W, Dardik A, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782-788.
48. Cynamon J, Stein EG, Dym J, et al. A new method for aggressive management of deep vein thrombosis: Retrospective study of the power pulse technique. J Vasc Interv Radiol 2006; 17: 1043-1049.
49. O'Sullivan G, Lohan DG, Gough N, et al. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol 2007; 18: 715-724.
50. Grewal NK, Martinez JT, Andrews L, Comerota AJ. Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity. J Vasc Surg 2010; 51: 1209-1214.
51. Ginsberg JS, Magier D, Mackinnon B, et al. Intermittent compression units for severe post-phlebitic syndrome: A randomized crossover study. CMAJ 1999; 160: 1303-1306.
52. O'Donnell MJ, McRae S, Kahn SR, et al. Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial. Thromb Haemost 2008; 99: 623-629.
53. Kahn SR, Shrier I, Shapiro S, et al. Six-month exercise training program to treat post-thrombotic syndrome: A randomized controlled two-centre trial. CMAJ 2011; 183: 37-44.
54. Neglén P, Hollis KC, Raju S. Combined saphenous ablation and iliac stent placement for complex severe chronic venous disease. J Vasc Surg 2006; 44: 828-833.
55. Vedantham S. Valvular dysfunction and venous obstruction in the post-thrombotic syndrome. Thromb Res 2009; 123 (Suppl 4): S62-S65.